A STUDY OF PLASMA FIBRINOGEN IN ACUTE ISCHEMIC AND HEMORRHAGIC STROKE PATIENTS

Authors

  • Dr. Kavish Chopda , Dr. Prakash Shende , Dr. Rahul Patil , Dr. Vikram Vikhe , Dr. Ranjith Kumaran , Dr. Harshad Patel

DOI:

https://doi.org/10.47750/pnr.2022.13.S09.943

Abstract

Aim: The aim of the present study was to evaluate the level of plasma fibrinogen in acute ischemic and hemorrhagic stroke.

Methods: The present descriptive Prospective Observational Study was conducted on 100 CT/ MRI confirmed cases of Stroke admitted in Medicine Dr. D.Y. Patil Medical College Hospital and Research Centre, Pimpri, Pune during the period from October 2020 to September 2022.

Results: The Mean Age group of study participants was 61.74±11.28 with 5% in 18-40 years, 6% in 41-50, 31% in 51-40, 41% in 61-70, 15% in 71-80 and 2% were above 80. There were 32% were females and 68% males. The most common symptom was headache followed by vomiting and seizures. Seizure was seen in 8 cases out of which 5 were hemorrhagic and 3 were ischemic infarct. The data showed 29% had Fibrinogen levels less than 350 and 71% had Fibrinogen levels more than 350.

Conclusion: The aim of the present study was to analyse the role of Serum Fibrinogen in patients with Acute Ischemic and Hemorrhagic Stroke. Our Study showed that Serum Fibrinogen both are elevated and can be considered as independent risk factors Of Stroke.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

A STUDY OF PLASMA FIBRINOGEN IN ACUTE ISCHEMIC AND HEMORRHAGIC STROKE PATIENTS. (2022). Journal of Pharmaceutical Negative Results, 8061-8068. https://doi.org/10.47750/pnr.2022.13.S09.943